A medical device company dedicated to addressing implant-related orthopedic infections caused by resilient biofilms, which are up to 1,000 times more resistant to conventional treatments and deadlier than breast cancer.
Ryan McManus
Venture: Sceptre Surgical
MBA ‘25
